ExodusPoint Capital Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.5M	Buy	+14,469	New	+$2.68M	0.02%	698
2025 Q4	–	Sell	-49,700	Closed	-$7.78M	–	1640
2025 Q3	$7.78M	Buy	+49,700	New	+$7.89M	0.11%	267
2024 Q4	–	Sell	-1,979	Closed	-$390K	–	1613
2024 Q3	$390K	Buy	+1,979	New	+$411K	﹤0.01%	1282
2024 Q1	–	Sell	-38,838	Closed	-$9.18M	–	1570
2023 Q4	$9.18M	Sell	38,838 -26,296	-40%	-$5.17M	0.11%	218
2023 Q3	$12.8M	Buy	65,134 +50,798	+354%	+$10.4M	0.16%	178
2023 Q2	$3.01M	Sell	14,336 -45,754	-76%	-$9.1M	0.04%	648
2023 Q1	$12.1M	Buy	60,090 +52,271	+669%	+$11.8M	0.14%	220
2022 Q4	$1.7M	Buy	+7,819	New	+$1.71M	0.03%	720
2022 Q1	–	Sell	-2,997	Closed	-$1.13M	–	2266
2021 Q4	$1.13M	Buy	+2,997	New	+$1.16M	0.01%	1008
2021 Q2	–	Sell	-96,183	Closed	-$27.9M	–	2423
2021 Q1	$27.9M	Buy	96,183 +84,720	+739%	+$23.5M	0.56%	27
2020 Q4	$2.86M	Sell	11,463 -49,620	-81%	-$11.8M	0.05%	413
2020 Q3	$13.8M	Buy	+61,083	New	+$12.7M	0.41%	50
2019 Q4	–	Sell	-1,700	Closed	-$225K	–	1586
2019 Q3	$225K	Buy	+1,700	New	+$228K	0.01%	1056